BlueWillow Biologics, Inc.

BlueWillow is a clinical-stage biotech company focused on developing intranasal allergy & infectious disease vaccines using its patented NanoVax® platform

  • Stage Product In Development
  • Industry Biotechnology
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded January 2017
  • Employees 14
  • Incorporation Type C-corp
  • Website bluewillow.com

Company Summary

BlueWillow is an emerging biotech company that is entering a very exciting time. We have exclusive rights to a proprietary nanotechnology that was discovered at the University of Michigan. We have received $70M in NIH & Gates grants to develop an intranasal NanoVax® platform for infectious disease and allergy vaccines. We are raising a $3M round to accelerate development of our peanut allergy vaccine, while NIH supports our other key programs.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free